ChromoGenics postpones publication of the financial report for the third quarter in 2023
The Board of Directors of ChromoGenics has decided to postpone the publication of the financial report for the third quarter in 2023.For practical reasons, the Board of Directors of ChromoGenics has decided to postpone the publication of the third quarterly report in 2023 until the 30[th] of November 2023. Previously communicated date for submission of the report was on the 23[rd] of November 2023. Contact: Fredrik Fränding, CEOAnne-Marie Gullman, CFO & Head of Investor Relations Tel: +46 (0) 18 430 0430E-mail: info@chromogenics.com ChromoGenics This information was